79326147 - NANOFORM

Information

• Trademark
• 79326147

• Source

• Serial Number

  79326147

• Registration Number

  7082475

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  April 07, 2021
  3 years ago

• Registration Date

  June 20, 2023
  a year ago

• Transaction Date

  October 10, 2023
  a year ago

• Status Date

  June 20, 2023
  a year ago

• Published for Opposition Date

  April 04, 2023
  a year ago

• Location Date

  June 20, 2023
  a year ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  SHINN, LAUREN DONGMI

• Attorney Docket Number

  5672.0038TM

  Attorney Name

  Mark E. Olds

  Law Office Assigned Location Code

  O10

• Owners

  • Nanoform Finland PLC

Case File Statements

• GS0401: Providing information relating to material treatment; processing of biopharmaceutical materials for others, namely, custom manufacture of biopharmaceutical materials; custom manufacture of biopharmaceuticals; bioremediation services; custom manufacture of pharmaceuticals; treatment of materials by means of modification of particles using chemical and physical processing and transformation processes, namely, manufacturing of pharmaceuticals; provision of information relating to chemical processing being a type of chemical treatment of materials; custom manufacture of medical devices for others; microencapsulating services provided for others
• DM0000: The mark consists of the stylized wording "NANOFORM" to the right of a design comprised of three wedges of a circle and seven circles.
• GS0091: Recorded bioinformatics software for capturing, computing, analyzing and interpreting biological data; apparatus for the transmission of data; apparatus for recording data; laboratory data processing apparatus for use in data collection; recorded data communications software; digital media, namely downloadable audio and video digital recordings that contain chemical properties; electronically prerecorded digital recordings featuring data in the field of science; laboratory equipment, namely an apparatus for detecting particles; laboratory apparatus and instruments, namely, particle size analyzers; laboratory apparatus and instruments, namely, particle flow monitors; recorded interactive databases featuring chemical properties of molecules; downloadable computer software for the management of data; downloadable computer software for analyzing drug particles relating to the medical field; nanoparticle size analysers; recorded computer data storage programs; recorded computer programmes for data processing; electronic data loggers; computer programs, recorded, for use in electronic storage of data; electronic databases in the field of pharmaceutical industry recorded on computer media; recorded computer database search engine software; recorded computer software for database synchronization; computer documentation in electronic form, in the nature of electronic publications, namely, manuals, software documentation being a type of manual, whitepapers, magazines, and articles featuring software design and development, database management, data processing, recorded on computer media; recorded computer databases in the field of pharmaceutical industry; recorded computer database servers in the field of pharmaceutical industry; recorded computer programs for accessing, browsing and searching online databases; recorded computer software for database management; recorded computer software to automate data warehousing; recorded computer software for application and database integration; recorded computer software for creating searchable databases of information and data; recorded computer software for authorising access to data bases; electronic databases recorded on computer media in the field of pharmaceutical industry
• GS0011: Active chemical ingredients for use in the manufacture of pharmaceuticals; biochemical substances in the nature of biochemical preparations for scientific purposes; biochemical preparations other than for medical use; biological substances in the nature of biochemical reagents other than for medial or veterinary use; biological activators, namely biochemical catalysts; biological inoculants, namely, biological microorganisms used in fermentation of silage, other than for medical use; biological preparations for use in industry and science; substances in the nature of plant hormones for promoting plant growth; plant growth regulating preparations; preservatives for plants; plant extracts for use in the manufacture of pharmaceuticals; chemicals for the protection of plants in the nature of plant preservatives, other than fungicides, weedkillers, herbicides, insecticides, parasiticides; nanopowders for industrial purposes; all the above goods only in the field of nanotechnology and drug particle engineering
• GS0441: Consultancy and information services relating to dispensing of biopharmaceutical products; consultancy and information services in the field of pharmaceutical products; provision of pharmaceutical information; advisory services in the field of pharmaceuticals; medical information services provided via the internet; rental of medical apparatus and installations in the field of medical technology; pharmacy advice, namely, pharmaceutical advice; medical counseling; medical screening; medical information; medical analysis services for the diagnosis and treatment of persons provided by a medical laboratory; providing medical information; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; advisory services relating to medical apparatus and instruments; advisory services relating to medical problems; preparation and dispensing of medications; providing information relating to the preparation and dispensing of medications
• GS0421: Scientific analysis in the field of molecular biology; analytical scientific laboratory services; advisory services relating to biochemistry; biochemistry consultancy; biochemical research and analysis; biochemical research and development; biochemical engineering services; research and development services in the field of biochemistry; scientific research relating to biology; biological research and analysis; biomedical research services; biological research laboratory services; biological research development services; biological research, clinical research in the field of pharmaceutical industry and medical research; scientific laboratory services in the nature of preparation of biological samples for testing and analysis in research laboratories; research in the field of biotechnology; consultancy relating to biotechnology; scientific and technological services, namely, scientific testing in the field of biotechnology; scientific research in the field of pharmacogenetics; consultancy relating to research in the field of pharmacogenetics; consultancy pertaining to pharmacology; pharmaceutical products development; pharmaceutical research and development; conducting clinical trials for others in the field of pharmaceutical products; pharmaceutical drug development services; development of pharmaceutical preparations and medicines; Testing services for assessing the efficiency of pharmaceuticals; testing of pharmaceuticals; pharmaceutical product evaluation; design of particles in the processing of pharmaceutical solids; scientific laboratory services of a chemical and biological laboratory; conducting clinical trials for others; provision of information and data relating to medical and veterinary research and development; design and development of computer software for use with medical technology; medical and pharmacological research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; design and development of medical technology; consultancy relating to pharmaceutical research and development; drug discovery services; inspection of pharmaceuticals; research on the subject of pharmaceuticals; research in the field of molecular sciences; providing on-line non-downloadable software for database management; electronic storage services for archiving databases; services for the provision of technological information, namely, providing technology information in the field of pharmaceutical industry; expert opinion relating to technology, namely, technological consultation in the field of computer databases; providing information about industrial scientific analysis and scientific research services; biotechnological research relating to industry; information on the subject of scientific research in the field of biochemistry and biotechnology; scientific research for medical purposes; scientific research in the field of pharmacy; scientific research conducted using databases; providing scientific and technological information; conducting clinical trials for others in the field of pharmaceuticals; providing information about the results of clinical trials for pharmaceutical products; design and development of computer database programs; consultancy relating to the design and development of computer database programs; rental of a database server to third parties; installation, maintenance and updating of database software; reconstruction of database systems for others; design and development of software for database management; database design and development; development, updating and maintenance of software and database systems; server hosting of databases; server hosting of computerized data, files, applications and information; writing of computer programs for medical applications; computer programming in the medical field; research and development for the pharmaceutical industry; research and development in the pharmaceutical and biotechnology fields; conducting early evaluations in the field of new pharmaceuticals

Case File Event Statements

• 10/10/2023 - a year ago

  43 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 9/21/2023 - a year ago

  42 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 9/21/2023 - a year ago

  41 - FINAL DISPOSITION PROCESSED Type: FIMP

• 9/20/2023 - a year ago

  40 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 6/20/2023 - a year ago

  39 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 6/20/2023 - a year ago

  38 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 5/9/2023 - a year ago

  37 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 4/19/2023 - a year ago

  36 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 4/19/2023 - a year ago

  35 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 4/5/2023 - a year ago

  34 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 4/4/2023 - a year ago

  33 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 4/4/2023 - a year ago

  32 - PUBLISHED FOR OPPOSITION Type: PUBO

• 3/15/2023 - a year ago

  31 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 3/15/2023 - a year ago

  30 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 3/15/2023 - a year ago

  29 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 3/2/2023 - a year ago

  28 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 3/2/2023 - a year ago

  27 - ASSIGNED TO LIE Type: ALIE

• 2/14/2023 - a year ago

  26 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 2/14/2023 - a year ago

  25 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 2/14/2023 - a year ago

  24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 2/10/2023 - a year ago

  23 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/9/2023 - a year ago

  22 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/9/2023 - a year ago

  21 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/5/2022 - 2 years ago

  20 - REFUSAL PROCESSED BY IB Type: RFNP

• 8/9/2022 - 2 years ago

  19 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 8/9/2022 - 2 years ago

  18 - NON-FINAL ACTION E-MAILED Type: GNRT

• 8/9/2022 - 2 years ago

  17 - NON-FINAL ACTION WRITTEN Type: CNRT

• 7/6/2022 - 2 years ago

  16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/5/2022 - 2 years ago

  15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/5/2022 - 2 years ago

  14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/7/2022 - 2 years ago

  13 - ATTORNEY REVIEW COMPLETED Type: ATRV

• 4/5/2022 - 2 years ago

  12 - LIMITATION FROM THE IB - REQUEST EXAM REVIEW Type: LIME

• 2/6/2022 - 2 years ago

  11 - REFUSAL PROCESSED BY IB Type: RFNT

• 1/28/2022 - 2 years ago

  10 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG

• 1/6/2022 - 2 years ago

  9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 1/5/2022 - 2 years ago

  8 - REFUSAL PROCESSED BY MPU Type: RFRR

• 12/14/2021 - 2 years ago

  7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 12/13/2021 - 2 years ago

  6 - NON-FINAL ACTION WRITTEN Type: CNRT

• 12/11/2021 - 2 years ago

  5 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 12/7/2021 - 2 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 12/7/2021 - 2 years ago

  3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 12/6/2021 - 2 years ago

  2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI

• 11/18/2021 - 3 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR